Tag: C-Path
-
C-Path Welcomes Rare Disease Advocacy Leader Ronald J. Bartek to Board of Directors
TUCSON, Ariz., Sept. 8, 2025 ⎯ Critical Path Institute® (C-Path) today announced the election of Ronald J. Bartek to its Board of Directors. Bartek’s experience spans leadership in rare disease advocacy […]
-
2025 C-Path Global Impact Conference
We’re excited to announce that registration is now open for the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC), taking place September 9–11 at the Washington Marriott at Metro […]
-
C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes
TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment for type 1 diabetes […]
-
Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration
TUCSON, Ariz., May 8, 2025 — The year 2025 marks a historic milestone for Critical Path Institute® (C-Path), as the organization celebrates 20 years of transforming the landscape of drug development […]
-
C-Path’s Predictive Safety Testing Consortium Advances a Transformative Test to Detect Drug Induced Liver Injury
Serum Glutamate Dehydrogenase Activity Enables Sensitive and Specific Diagnosis of Hepatocellular Injury in Humans TUCSON, Ariz., March 27, 2025 – Researchers from Critical Path Institute’s® (C-Path) Predictive Safety Testing Consortium have […]
-
C-Path Announces Jennifer Kendra as New Vice President of Strategic Relationships
New Leadership to Drive Expansion of Collaborative Initiatives and Fundraising Strategies at C-Path TUCSON, Ariz., January 23, 2025 — Critical Path Institute® (C-Path) today announced the appointment of Jennifer Kendra as […]
